Skip to main content
. 2015 Nov 12;78(4):309–314. doi: 10.1007/s12262-015-1386-5

Table 2.

Distribution of the patients according to the pTNM staging (2009)

Parameter All cases (n = 16) Sporadic forms (n = 9) Hereditary forms (n = 7) p a
T1 (n, %) 5 (31.2) 1 (11.1) 4 (57.1) NS
T2 (n, %) 6 (37.5) 4 (44.5) 2 (28.6) NS
T3 (n, %) 3 (18.8) 2 (22.2) 1 (14.3) NS
T4a-b (n, %) 2 (12.5) 2 (22.2) 0 (0) NS
N1a (n, %) 1 (6.3) 1 (11.1) 0 (0) NS
N1b (n, %) 2 (12.5) 1 (11.1) 1 (14.3) NS
M1 (n, %) 1 (6.3) 1 (11.1) 0 (0) NS
Stage I (n, %) 5 (31.2) 1 (11.1) 4 (57.1) NS
Stage II (n, %) 7 (43.8) 5 (55.6) 2 (28.6) NS
Stage III (n, %) 1 (6.3) 1 (11.1) 0 (0) NS
Stage IVa–c (n, %) 3 (18.8) 2 (22.2) 1 (14.3) NS

NS not significant

a p between sporadic and hereditary forms